The Trump administration's WISeR pilot program introduces AI-driven prior authorization in Medicare to reduce waste and fraud, raising concerns over patient care and regulatory oversight.

Explore how AI-powered predictive analytics improve diabetes management and reduce Medicare costs through personalized patient adherence interventions.

Medicare telehealth waivers enabling expanded coverage during COVID-19 expire in 2025. Providers must prepare for significant Medicare and regulatory changes affecting telehealth reimbursement and compliance.

The Trump administration's $100,000 H-1B visa fee poses challenges for the healthcare workforce, especially in rural areas, amid hospital closures, regulatory penalties, and healthcare market shifts.

TailorCare extends its value-based musculoskeletal care program to Humana Medicare Advantage members in Dallas and Denver, enhancing personalized care coordination and outcomes.

Medicare Advantage incurs a $5.7 billion underwriting loss in 2024 due to increased utilization, medical inflation, and regulatory changes, impacting insurer profitability and market dynamics.

SelectQuote Inc. faces a DOJ whistleblower lawsuit over Medicare Advantage sales practices, triggering stock declines and investor class-action suits. Key updates on regulatory compliance and market impact.

Understand critical Medicare enrollment periods, penalties, and coverage options to inform insurance professionals and advisors guiding clients through retirement healthcare transitions.

The Patients Over Profits Act aims to prohibit ownership of both health plans and providers to curb vertical integration in Medicare-related markets, impacting major payviders like UnitedHealth Group and influencing U.S. healthcare market competition and regulatory enforcement.

Humana's stock sees an 18% decline over 12 months despite 7% revenue and 21% net income growth. Regulatory and operational challenges may impact future earnings.